Baltina, L.A.,
Hour, M.-J.,
Liu, Y.-C.,
Chang, Y.-S.,
Huang, S.-H.,
Lai, H.-C.,
Kondratenko, R.M.,
Petrova, S.F.,
Yunusov, M.S.,
Lin, C.-W. (2021) Natal RGN
single-round infectious particles, respectively. The lead compound was 14 with a high
Baxter, J.S.,
Johnson, N.,
Tomczyk, K,
Gillespie, A.,
Maguire, S.,
Brough, R.,
Fachal, L,
Michailidou, K.,
Bolla, M.K.,
Wang, Q.,
Dennis, J.,
Ahearn, T.U.,
Bermisheva, M. (2021) receptor alpha ChIP-seq peaks) to generate a
single extended regulatory element. This regulatory element
Buzaev, Igor V.,
Galimova, Rezida M.,
Nabiullina, Dinara I.,
Illarioshkin, Sergey N.,
Zagidullin, Naufal Sh.,
Safin, Shamil M. (2023) and evaluate the methodology of remote MRgFUS proctorship. Methods: This
single-center, nonrandomized
Zhang, G.,
Zhu, Y.,
Ling, Y.,
Chen, P.,
Dai, J.,
Wang, Ch.,
Xu, Sh.,
Shumadalova, A.,
Shi, H. (2022) strategy for patients with AIS caused by PPCA remains unclear. We discuss our
single-center experience
Motloch, LJ;,
Jirak, P;,
Gareeva, D;,
Davtyan, P;,
Gumerov, R;,
Lakman, I;,
Tataurov, A;,
Zulkarneev, R;,
Kabirov, I;,
Cai, BZ;,
Valeev, B;,
Pavlov, V;,
Kopp, K;,
Hoppe, UC;,
Lichtenauer, M;,
Fiedler, L;,
Pistulli, R;,
Zagidullin, N (2022) single, tertiary care center. Patient clinical and laboratory characteristics and the concentration